Evaluation of Walgreens Company

Walgreens CO. |
EVALUATION OF WALGREENS CO. |
Managerial finance project |
|


Contents
Walgreens CEO 1
The board of directors 2
How much trading volume is there on the stock? 4
Does the firm has any   has publicly traded debt? 4
Societal constraint 4
Liquidity ratios 4
Overall risk of   company 8
Marginal investors in the company 9
Estimate the default risk and cost of debt   of your company 9
Weights of debt and equity 10
Regression 10
WACC and CAPM 11
Evaluating the firm´s current investment 12
Choice of the optimal financing mix 13
Analyses of the current financing decisions 14
Dividend Policy Evaluation 15

Walgreens CEO
Gregory D. Wasson is the president of Walgreens, and CEO effective since February 1, 2009. Wasson joined the company as a pharmacy intern in 1980 while attending Purdue University’s school of pharmacy, and managed stores in the Houston area before being promoted to a district manager position in 1986. Wasson was promoted to a regional vice president of the store operations division in 1999. In 2001, he was promoted again to Walgreens vice president and made an executive vice president of Walgreens Health Initiatives, the company’s pharmacy benefit manager (PBM). Wasson was promoted to president of Walgreens Health Initiatives in 2002, Walgreens senior vice president in 2004 and to a Walgreens executive vice president in 2005. He was named president and chief operating officer of Walgreens in 2007. Following the departure of Jeff Rein from the position of CEO, Wasson was chosen as the new officer after a nationwide search for candidates, the first including external possibilities. He sits on the Board of Directors of the Consumer Goods Forum.
Wasson, 54, received compensation valued at about $12 million for the fiscal year that ended Aug. 31, according to the Deerfield, Ill., company's annual proxy statement filed Monday. That represented a 1 percent drop compared to fiscal 2011.
Wasson, who became... [continues]

Read full essay